Advances in Clinical Chemistry
Directeur de Collection : Makowski Gregory S.
Advances in Clinical Chemistry, Volume 87, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry, and is the benchmark for novel analytical approaches in the clinical laboratory.
1. Long Noncoding RNAs: Advances in Lipid Metabolism Yongzhi Zeng, Kun Ren, Xiao Zhu, Zhi Zheng, and Guanghui Yi 2. Protein Carbamylation in Chronic Kidney Disease and Dialysis Joshua Long, Xavier Vela Parada, and Sahir Kalim 3. Serum Ethanolamine Plasmalogen and Urine Myo-Inositol as Cognitive Decline Markers Ryouta Maeba, Atsushi Araki, and Yoshinori Fujiwara 4. Free Circulating miRNA Measurement in Clinical Settings: the Still Unsolved Issue of the Normalization Martina Faraldi, Marta Gomarasca, Giuseppe Banfi, and Giovanni Lombardi 5. Glutathione as a Marker for Human Disease Garrett Teskey, Rachel Abrahem, Ruoqiong Cao, Karo Gyurjian, Hicret Islamoglu, Mariana Lucero, Andrew Martinez, Erik Paredes, Oscar Salaiz, Brittanie Robinson, and Vishwanath Venketaraman 6. Fecal Calprotectin Ruth M. Ayling and Klaartje Kok
- Provides the most up-to-date technologies in clinical chemistry and clinical laboratory science
- Authored by world renowned clinical laboratory scientists, physicians and research scientists
- Presents the international benchmark for novel analytical approaches in the clinical laboratory
Date de parution : 10-2018
Ouvrage de 212 p.
15x22.8 cm
Thèmes d’Advances in Clinical Chemistry :
Mots-clés :
Aamyloid-beta; Adipogenesis; Ageing; Alzheimer'’s disease; Bbiomarker; Biomarkers; Cancer; Carbamoylation; Carbamylation; Ccalprotectin; Ccognitive impairment; Chronic kidney disease; Crohn'’s disease; Diabetes; Dialysis; Dyslipidemias; Eethanolamine plasmalogen; End stage renal disease; Ffecal marker; Glutathione; Hhyperglycemia; HIV; Iinflammatory bowel disease; Iinsulin resistance; Lipids metabolism; Long non-coding RNAs; Metabolic disease; microRNA; Normalization; Posttranslational protein modification; Pperoxisome; Reference genes; RT-qPCR; Ttype 2 diabetes mellitus; Tuberculosis; Urea; Uremia; Uulcerative colitis; Uurinary myo-inositol